CALR and essential thrombocythemia: Because CALR mutations occur in multipotent progenitor cells that can differentiate into erythroid and myeloid lineage cells [10], we hypothesize that these mutations play a role in tumorigenesis not only in the megakaryocytes of ET and PMF patients, but also in the erythroid cells of PV patients.